About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,806 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,806 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1381-1400 of 10,806 trials

CompletedValidation of an Assay to Measure Cyclooxygenase-1 ActivityThe purpose of this study is to obtain a reference range for a newly developed assay of ex vivo platelet COX-1 activity in normal volunteers taking a routine clinical dose of…NCT00761891·Nashville, Tennessee CompletedDeterminants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 2This study aims to assess the effect of controlled dietary lysine intake on plasma and urine α-aminoadipic acid (2-AAA).NCT04417218·Nashville, Tennessee TerminatedMulticenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung CancerThe purpose of this study is to evaluate the safety and anti-tumor effect of rociletinib.NCT02147990·Alhambra, California and 90 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

RecruitingArterial Stiffness and Blood PressureHypertension is a common and treatable disorder that remains the leading preventable cause of heart disease.NCT06495710·Birmingham, Alabama and 2 others

WithdrawnER Stress in NAFLDThe investigators overall hypothesis is that exacerbation of endoplasmic reticulum (ER) stress in the liver is associated with significant alterations in phosphatidylcholines that…NCT01807910·Nashville, Tennessee

UnknownStudy to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With SchizophreniaTo establish the proof of concept that MEM 3454, used as add-on pharmacotherapy, is a safe and effective treatment in patients with cognitive impairment associated with…NCT00604760·Lemon Grove, California and 43 others

TerminatedExtension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated PainThe primary objective of this extension study is to assess the maintenance of efficacy of linzagolix administered orally once daily for up to an additional 6 months (for up to 12…NCT04372121·Little Rock, Arkansas and 24 others

CompletedA Phase I Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2118436 in Subjects With Solid TumorsBRF112680 is a first-time-in-human study to establish the recommended dose and schedule of the orally administered GSK2118436.NCT00880321·Los Angeles, California and 7 others

RecruitingTesting Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian CancerThis phase III trial compares the effect of olaparib for one year versus two years, with or without bevacizumab, for the treatment of BRCA 1/2 mutated or homologous recombination…NCT06580314·Birmingham, Alabama and 694 others

CompletedLong-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset SeizuresTo allow pediatric patients with partial onset seizures an opportunity to receive (as follow-up to studies N01009(NCT00105040)/N01103(NCT00175890) or by direct enrollment)…NCT00152516·Mobile, Alabama and 83 others

Active not recruitingA Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast CancerThe main purpose of this study is to evaluate the safety and efficacy of abemaciclib plus tamoxifen or abemaciclib alone in women with previously treated hormone receptor-positive…NCT02747004·Tucson, Arizona and 58 others

CompletedStudy to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced CancerThis is a Phase 1, open-label, multi-center, first time in human study of AMP-224 in adult patients with cancer that is not responding to standard therapy.NCT01352884·Detroit, Michigan and 3 others

CompletedStudy To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's DiseaseThe objectives of this study are to evaluate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06651600 (200 mg for 8 weeks followed by 50 mg for 4…NCT03395184·Dothan, Alabama and 194 others

CompletedQuality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or AcquaintanceRATIONALE: Studying quality of life in breast cancer survivors may help determine the long-term effects of breast cancer and may help improve the quality of life for future breast…NCT00309933·Monterey, California and 103 others

CompletedAn Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 DiabetesThis is an open label, observational study designed to collect data that characterize the use of SYMLIN following the introduction of the medication into the marketplace.NCT00229658·Birmingham, Alabama and 106 others

CompletedCYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)The goal of this clinical study is to determine the safety, pharmacokinetics, pharmacodynamics and efficacy and activity of seviteronel, a lyase-selective inhibitor of CYP17, in…NCT02580448·Birmingham, Alabama and 35 others

CompletedA Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced CancerThe main purpose of this study is to investigate the safety of prexasertib in combination with other anti-cancer drugs (cisplatin, cetuximab, pemetrexed, fluorouracil or…NCT02124148·Sarasota, Florida and 4 others

TerminatedA Study of MLN0264 in Patients With Pancreatic CancerThe purpose of this study is to assess the efficacy, safety and tolerability of MLN0264 in patients with advanced or metastatic guanylyl cyclase C (GCC)-positive adenocarcinoma of…NCT02202785·Aurora, Colorado and 15 others

CompletedM7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC)The main purpose of the study was to evaluate the safety and tolerability of M7824 in combination with chemotherapy.NCT03840915·Fountain Valley, California and 18 others

Active not recruitingDaunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction ChemotherapyThis phase II/III trial studies how well daunorubicin and cytarabine with or without uproleselan works in treating older adult patients with acute myeloid leukemia receiving…NCT03701308·Little Rock, Arkansas and 187 others

PreviousPage 70 of 541Next

Diabetes

in Nashville

Heart Diseasein Nashville